Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chloramphenicol resistance (Cmlr) of Streptomyces coelicolor A3(2) behaves like a transposon locus, not being localisable in any region of the map and yet being transferable in crosses at a rate comparable to that of chromosomal markers. It can also be transposed onto a plasmid (
SCP1
) and back to the chromosome. Some traits, such as arginino-succinate synthase production (ArgG), aerial mycelium formation (AmyA), resistance to tetracycline and to rifamycin C appear to be joined to Cml in three processes: co-mutation, i.e. simultaneous loss, post-mutation, i.e. spontaneous loss at high frequency in subclones from Cmls strains, co-transfer, i.e. joint transfer with the
cml
locus in crosses or during infection by the aggregate
SCP1
::SCTn1 plasmid. All these processes have been consistently observed with special attention to the argG locus.
...
PMID:Properties of transposon SCTn1 of Streptomyces coelicolor A3(2). 631 Mar 49
The gene expression of a new group of tumour antigens known as cancer/testis (CT) antigens is now well-recognized in some solid tumours. However, their expression in haematological malignancies remained unclear. In this study, we have used reverse transcription polymerase chain reaction and Southern blot analysis to examine the presence of transcripts for the three CT antigens, NY-ESO-1, SSX2 and
SCP1
in haematological malignant cells. We found that transcripts for
SCP1
could be detected in 10% of myeloma, 5.7% of acute myeloid leukaemia and 23% of
chronic myeloid leukaemia
. In contrast, NY-ESO-1 and SSX2 were not detected in any of the 107 tumour samples.
...
PMID:Expression of testicular genes in haematological malignancies. 1058 77